| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 09/14/2004 | US6790593 Metallocenyl-phthalocyanines |
| 09/10/2004 | WO2004076459A1 Quaternary ammonium bifluoride compound and process for producing nitroalcohol with the same |
| 09/10/2004 | WO2004076458A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/10/2004 | WO2004076457A1 Solvent-free process for the preparation of pyrrolo (3,4c) pyrrole compounds |
| 09/10/2004 | WO2004076456A1 Solvent-free process for the preparation of diketopyrrolopyrrole derivatives |
| 09/10/2004 | WO2004076449A2 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 09/10/2004 | WO2004076411A2 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |
| 09/10/2004 | WO2004076384A2 Protection of amine and hydroxyl groups using fluoroacylation |
| 09/10/2004 | WO2004076383A1 Mono amine and diamine derivatives of cl-20 |
| 09/10/2004 | WO2004075890A1 Medicinal composition containing stabilized imidazole derivative and method of stabilizing imidazole derivative |
| 09/10/2004 | WO2004075863A2 Cxcr3 antagonists |
| 09/10/2004 | WO2004075847A2 METHODS AND COMPOUNDS FOR THE TREATMENT OF Aß ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS |
| 09/10/2004 | WO2004075846A2 Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| 09/10/2004 | WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators |
| 09/10/2004 | WO2004014352A3 Methods for treating carbonic anhydrase mediated disorders |
| 09/10/2004 | WO2003101999A3 Preparation of metal mesoporphyrin halide compounds |
| 09/10/2004 | WO2003027067A3 Process for making carbapenem compounds |
| 09/10/2004 | CA2516824A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/10/2004 | CA2516705A1 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |
| 09/09/2004 | US20040176603 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions |
| 09/09/2004 | US20040176591 Novel synthesis and crystallization of peperazine ring-containing compounds |
| 09/09/2004 | US20040176438 Novel mono- and di-fluorinated beozothiepine copmunds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake |
| 09/09/2004 | US20040176433 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
| 09/09/2004 | US20040176400 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 09/09/2004 | US20040176398 for controlling unwanted microorganisms |
| 09/09/2004 | US20040176397 (Oxo-Pyrazolo[1,5a]pyrimidin-2-yl)Alkyl-Carboxamides |
| 09/09/2004 | US20040176396 anti-protoazoal; poultry feed; therapy for cytokine mediated disease i.e. osteoarthritis, cerebral malaria, chronic pulmonary inflammatory disease, silicosis, pulmonary sarcosis, bone resorption diseases, reperfusion injury, graft v. host rejection |
| 09/09/2004 | US20040176390 Novel fused heteroaromatic compounds as transforming growth factor (TGF) inhibitors |
| 09/09/2004 | US20040176379 agonist effect from one or more of a somatostatin subtype receptor; diabetes mellitus, hyperlipidemia, insulin insensitivity, Syndrome X; inhibiting the proliferation of helicobacter pylori |
| 09/09/2004 | US20040176376 Pyrazolotriazines as CRF antagonists |
| 09/09/2004 | US20040176371 1,6-Dihydropyrazolo[4,3-d]pyridine-7-thione derivatives; phosphodiesterase inhibitors; side effect reduction; chlorosulfonation; thionation |
| 09/09/2004 | US20040176351 Process for making carbapenem compounds |
| 09/09/2004 | US20040176325 P38 MAP kinase inhibitors comprising indazole derivatives; antiinflammatory and antiproliferative agents; autoimmune, bone, and neurodegenerative disorders; viricides, infections |
| 09/09/2004 | US20040176324 Derivatives of 4,7-ethanothiopyrano[3,4-c]pyrrole-1,3-(2H)-dione, 4,7-epoxy-1H-isoindole-1,3(2H)-dione, and/or 4,7-ethano-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione derivatives; autoimmune diseases; anticarcinogenic agents |
| 09/09/2004 | DE10308107A1 New macrocyclic peptide derivatives useful for treating bacterial infections, especially caused by Gram-positive bacteria |
| 09/08/2004 | EP1454910A1 Substituted pyrimidinyl-2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 09/08/2004 | EP1454909A1 Substituted 8'-pyridinyl-dihydrospiro-(cycloalkyl)-pyrimido(1,2-a) pyrimidin-6-one and 8'-pyrimidinyl-dihydrospiro-(cycloalkyl)-pyrimido(1,2-a)pyrimidin-6-one derivatives and their use against neurodegenerative diseases |
| 09/08/2004 | EP1454908A1 Substituted pyridinyl-2-(diaza-bicyclo-alkyl)-pyrimidinone derivatives |
| 09/08/2004 | EP1454897A1 PYRAZOLOPYRIMIDINONE DERIVATIVES HAVING PDE7−INHIBITORY ACTIVITY |
| 09/08/2004 | EP1453836A1 1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A 2a RECEPTOR ANTAGONISTS |
| 09/08/2004 | EP1453835A2 Adenosine a 2a receptor antagonists |
| 09/08/2004 | EP1453832A1 Ring fused pyrazole derivatives |
| 09/08/2004 | EP1453828A2 Azabicyclic compounds for the treatment of fibromyalgia syndrome |
| 09/08/2004 | EP1453813A2 IMPROVED PURIFICATION OF 4, 4'(5')-DI- i t /i -BUTYLCYCLOHEXANO-18-CROWN-6 |
| 09/08/2004 | EP1453812A2 Cytotoxic agents |
| 09/08/2004 | EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/08/2004 | EP1453506A2 Topoisomerase poison agents |
| 09/08/2004 | EP1345603A4 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 09/08/2004 | EP1268408B1 Arthropodicidal carboxanilides |
| 09/08/2004 | EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 09/08/2004 | EP1084114B1 Isothiazole derivatives useful as anticancer agents |
| 09/08/2004 | EP0824524B1 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase |
| 09/08/2004 | CN1527712A Active ingredient combination for medicamentous therapy of nicotine dependency |
| 09/08/2004 | CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications |
| 09/08/2004 | CN1527701A Tablets quickly disintegrated in oral cavity |
| 09/08/2004 | CN1165537C Pyrroloindoles, pyridoindoles and azepinoindoles as 5-HT2c agonists |
| 09/08/2004 | CN1165532C Substituted 3-cyanoquinolines as protein tyrosine kinase inhibitors |
| 09/08/2004 | CN1165303C DNA binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents |
| 09/08/2004 | CN1165279C Dyeing composition containing pyrazolo-[1,5-alpha]-pyrimiding as oxidation base and naphthalene coupling agent, and dyeing method |
| 09/07/2004 | US6787549 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder |
| 09/07/2004 | US6787547 Compound and method for the treatment of pain |
| 09/07/2004 | US6787545 Secretory phospholipase a2 mediated fatty acid release |
| 09/07/2004 | US6787543 Preparation of tachykinin antagonists; substituted nitrogen-containing heterocycles |
| 09/07/2004 | US6787540 Compounds useful as reversible inhibitors of cysteine proteases |
| 09/07/2004 | US6787294 Photographic material comprising a bicyclic pyrazolotriazole coupler with improved hue |
| 09/02/2004 | WO2004074292A1 Exo-(t-butyl 2r(+))-2-amino-7-azabicyclo[2.2.1]heptane-7-carboxylate, intermediates, and process to prepare and isolate them |
| 09/02/2004 | WO2004074291A1 Triazole compounds useful in therapy |
| 09/02/2004 | WO2004074290A1 Substituted amino heterocycles as vr-1 antagonists for treating pain |
| 09/02/2004 | WO2004074289A1 6-substituted imidazopyrazines |
| 09/02/2004 | WO2004074274A1 Substituted n-aryl nitrogen heterocycles |
| 09/02/2004 | WO2004074270A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 09/02/2004 | WO2004074259A1 Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compounds |
| 09/02/2004 | WO2004056324A3 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists |
| 09/02/2004 | WO2004014851A3 Tyrosine kinase inhibitors |
| 09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/02/2004 | US20040171847 From a pyrrolidinone compound; coloring high molecular weight material |
| 09/02/2004 | US20040171666 Rapid, thorough absorption; eliminates gastrointestional disorder and reduces central nervous system stimulation side effects; low cost |
| 09/02/2004 | US20040171602 involve modifying the apical ligands associated with the central metal component of metallotexaphyrins; Changing the pharmacokinetics and/or the biodistribution of the complex in this fashion may result in, for example, better clearance |
| 09/02/2004 | US20040171541 combination comprising a polypeptide comprising the modulating sequence of the erythropoietin receptor and a non-peptide organic molecule in the treatment of anemia |
| 09/02/2004 | US20040171520 Melanocortin receptor-specific peptidomimetics |
| 09/02/2004 | US20040171022 Methods for regulating transcription by targeting quadruplex DNA |
| 09/02/2004 | US20040170863 Organic electroluminescent devices using double-spiro organic compounds |
| 09/02/2004 | US20040170573 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route |
| 09/02/2004 | US20040170569 Dosage forms that rapidly produces peak plasma concentrations; heating a thin layer of the drug on a solid support to form a vapor; and passing air through the heated vapor to produce aerosol particles having less than 10% drug degradation products |
| 09/02/2004 | US20040169463 Aryl-aryl dendrimers |
| 09/02/2004 | US20040169175 Electronic device comprising organic compound having p-type semiconducting characteristics |
| 09/02/2004 | DE10307142A1 Substituierte N-Aryl-Stickstoffheterocyclen Substituted N-aryl nitrogen heterocycles |
| 09/02/2004 | CA2516590A1 Substituted n-aryl nitrogen heterocycles |
| 09/02/2004 | CA2516329A1 Exo-(t-butyl 2r(+))-2-amino-7-azabicyclo[2.2.1]heptane-7-carboxylate, intermediates, and process to prepare and isolate them |
| 09/02/2004 | CA2516235A1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 09/02/2004 | CA2516021A1 6-substituted imidazopyrazines |
| 09/02/2004 | CA2514908A1 Substituted amino heterocycles as vr-1 antagonists for treating pain |
| 09/02/2004 | CA2508731A1 Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compounds |
| 09/01/2004 | EP1452534A1 Pleuromutlin derivatives as antimicrobials |
| 09/01/2004 | EP1452528A1 Xanthine oxidase inhibitors |
| 09/01/2004 | EP1452525A1 Amide derivatives and drugs |
| 09/01/2004 | EP1451196A1 The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 09/01/2004 | EP1451192A1 Novel crystalline compound |
| 09/01/2004 | EP1451191A1 Thioether substituted imidazoquinolines |
| 09/01/2004 | EP1451161A1 Imidazopyridines, pyrimidines and triazines for enhancing cognition as gaba-a alpha 5 receptor subtype ligands |